Zusammenfassung
Angiotensin-I-converting-Enzym (ACE, CD143) ist eine von Endothelzellen transmembran exprimierte Zn2+-Dipeptidylpeptidase, die durch Bildung von Angiotensin II und Degradation von Bradykinin vasokonstriktorisch wirkt. Wir überprüften immunhistochemisch die endotheliale ACE-Expression in der humanen pulmonalen Strombahn in Lungengewebeproben von 39 Patienten (20 Frauen, 19 Männer; 34–76 Jahre). In allen Proben zeigten die pulmonalkapillären Endothelzellen die stärkste Expression, gefolgt von denen der Arteriolen und Arterien. In Venolen sowie Venen fand sich keine nennenswerte ACE-Expression. Statistisch signifikant waren die Intensitätsunterschiede zwischen den Gefäßtypen (p<0,001), jedoch nicht bezüglich des Geschlechts. Es kann somit ein gefäßtypspezifisches ACE-Expressionsmuster der pulmonalen Strombahn belegt werden. Dies weist ACE als endothelialen Marker für diese Lungengefäße aus.
Abstract
Angiotensin I converting enzyme (ACE, CD143) is an endothelial transmembrane Zn2+-dipeptidylpeptidase. By formation of angiotensin II and degrading bradykinin it acts as a vasoconstrictor. We examined endothelial ACE expression in human pulmonary vessels in specimens from 20 female and 19 male patients (age: 34–76 years) by immunohistochemistry. In all specimens, capillary endothelial cells showed the strongest expression, followed by those in arterioles and arteries. Venules and veins showed next to no staining. The differences in staining intensities were significant (P<0.001). Sex affected neither the expression intensity nor the expression pattern. Summarizing, we demonstrate the existence of a vessel-type specific ACE expression pattern for pulmonary vessels. The nearly exclusive endothelial ACE expression in capillaries and arterial vessels points to ACE as an immunohistochemical marker for these vessels in normal lung tissue.
Literatur
Baudin B, Berard M, Carrier JL, Legrand Y, Drouet L (1997) Vascular origin determines angiotensin I-converting enzyme expression in endothelial cells. Endothelium 5: 73–84
Baudin B (2002) New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 40: 256–265
Beneteau B, Baudin B, Morgant G, Giboudeau J, Baumann FC (1986) Automated kinetic assay of angiotensin-converting enzyme in serum. Clin Chem 32: 884–886
Britten MB, Zeiher AM, Schachinger V (1999) Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med 245: 315–327
Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE (1998) Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 32: 965–971
Brown NJ, Vaughan DE (1998) Angiotensin-converting enzyme inhibitors. Circulation 97: 1411–1420
Cushman DW, Cheung HS (1971) Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta (1971) 250: 261–265
Danilov SM, Franke FE, Erdos EG (1997) CD143 (angiotensin-converting enzyme) Workshop Panel report on endothelial cell markers. In: Kishimoto T et al. (eds) Leucocyte typing VI. Garland Publishing, New York, pp 746–751
Danilov SM, Gavrilyuk VD, Franke FE et al. (2001) Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol 280: L1335–347
Drexler H, Hornig B (1999) Endothelial dysfunction in human disease. J Mol Cell Cardiol 31: 51–60
Drouet L, Baudin B, Baumann FC, Caen JP (1988) Serum angiotensin-converting enzyme: an endothelial cell marker. Application to thromboembolic pathology. J Lab Clin Med 112: 450–457
Dzau VJ, Bernstein K, Celermajer D et al. (2001) Working Group on Tissue Angiotensin-converting enzyme, International Society of Cardiovascular Pharmacotherapy. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 88: 1L–20L
Ferreira SH, Vane JR (1967) The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Br J Pharmacol 30: 417–424
Franke FE, Pauls K, Metzger R, Danilov SM (2003) Angiotensin I-converting enzyme and potential substrates in human testis and testicular tumors. APMIS 2003 111: 234–243
Gaertner R, Prunier F, Philippe M, Louedec L, Mercadier JJ, Michel JB (2002) Scar and pulmonary expression and shedding of ACE in rat myocardial infarction. Am J Physiol Heart Circ Physiol 283: H156–164
Gillis CN, Roth JA (1977) The fate of biogenic monoamines in perfused rabbit lung Br J Pharmacol 59: 585–590
Marshall RP (2003) The pulmonary renin-angiotensin system. Curr Pharm Des 9: 715–722
Müller AM, Nesslinger M, Skipka G, Müller K-M (2002) On the expression of CD 34 by pulmonary endothelial cells in vivo. Pathobiology 70: 11–17
Müller AM, Skrzynski C, Skipka G, Muller KM (2002) Expression of von Willebrand factor by human pulmonary endothelial cells in vivo. Respiration 69: 526–533
Ng KK, Vane JR (1968) Fate of angiotensin I in the circulation. Nature 218: 144–150
Orfanos SE, Chen XL, Burch SE, Ryan JW, Chung AY, Catravas JD (1994) Radiation-induced early pulmonary endothelial ectoenzyme dysfunction in vivo: effect of indomethacin. Toxicol Appl Pharmacol 124: 112–122
Orfanos SE, Armaganidis A, Glynos C et al. (2000) Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation 102: 2011–2018
Orte C, Polak JM, Haworth SG, Yacoub MH, Morrell NW (2000) Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol 192: 379–384
Remmele W, Hildebrand U, Hienz HA et al. (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol 409: 127–147
Schmaier AH (2003) The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. Am J Physiol Regul Integr Comp Physiol 285: R1–13
Scrobohaci ML, Drouet L, Monem-Mansi A, Devergie A, Baudin B, D’Agay MF, Gluckman E (1991) Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res 63: 509–519
Stevens T, Rosenberg R, Aird W et al. (2001) NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am J Physiol Cell Physiol 281: C1422–1433
Tamaru N, Watanabe K, Yoshida M, Reitz-Vick DM, Townsend L, Glover J (2000) Angiotensin-converting enzyme activity by canine pulmonary microvascular and central pulmonary artery endothelial cells exposed to hypoxia. Lung 178: 249–255
Vanhoutte PM (1989) Endothelium and control of vascular function. State of the Art lecture. Hypertension 13: 658–667
Wu QY, Drouet L, Carrier JL, Rothschild C, Berard M, Rouault C, Caen JP, Meyer D (1987) Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis 7: 47–54
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müller, A.M., Gruhn, K., Lange, S. et al. Angiotensin-I-converting-Enzym (ACE, CD143) in regelrechtem humanem Lungengewebe. Pathologe 25, 141–146 (2004). https://doi.org/10.1007/s00292-004-0681-x
Issue Date:
DOI: https://doi.org/10.1007/s00292-004-0681-x